Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Northwest Biotherapeutics (NWBO) Interest Coverage Ratio: 2010-2025

Historic Interest Coverage Ratio for Northwest Biotherapeutics (NWBO) over the last 16 years, with Sep 2025 value amounting to -5.46.

  • Northwest Biotherapeutics' Interest Coverage Ratio rose 23.22% to -5.46 in Q3 2025 from the same period last year, while for Sep 2025 it was -7.60, marking a year-over-year increase of 21.49%. This contributed to the annual value of -8.56 for FY2024, which is 19.15% up from last year.
  • Northwest Biotherapeutics' Interest Coverage Ratio amounted to -5.46 in Q3 2025, which was up 32.50% from -8.09 recorded in Q2 2025.
  • In the past 5 years, Northwest Biotherapeutics' Interest Coverage Ratio ranged from a high of -5.46 in Q3 2025 and a low of -15.37 during Q2 2021.
  • Moreover, its 3-year median value for Interest Coverage Ratio was -10.37 (2024), whereas its average is -9.38.
  • Per our database at Business Quant, Northwest Biotherapeutics' Interest Coverage Ratio plummeted by 116.05% in 2021 and then skyrocketed by 52.26% in 2022.
  • Over the past 5 years, Northwest Biotherapeutics' Interest Coverage Ratio (Quarterly) stood at -9.26 in 2021, then tumbled by 60.79% to -14.89 in 2022, then grew by 18.11% to -12.19 in 2023, then surged by 39.01% to -7.44 in 2024, then grew by 23.22% to -5.46 in 2025.
  • Its last three reported values are -5.46 in Q3 2025, -8.09 for Q2 2025, and -10.81 during Q1 2025.